Chemoimmunotherapy Transforms Treatment in Nonsquamous NSCLC
Published: Thursday, Oct 31, 2019
Edward S. Kim, MD
The combination of immunotherapy and chemotherapy has shown unprecedented survival in patients with newly diagnosed advanced nonsquamous non–small cell lung cancer (NSCLC), said Edward S. Kim, MD.
... to read the full story